Shane Bouchard Email

Senior Director, Business Development & Strategic Alliances . Viridian Therapeutics

Current Roles

Employees:
227
Revenue:
$35.2M
About
Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today's therapies. Viridian's most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colo., with research and development operations in Waltham, Mass.
Viridian Therapeutics Address
221 Crescent Street
Boulder, CO
United States
Viridian Therapeutics Email